Physician profile
Mahtab U Ahmed
NPI 1891755021
$2,573.55
in general payments reported to CMS, 2019-2025
8 companies · $2,189 in 2025
The $2,189 reported for 2025 was more than what 81% of Obesity Medicine (Family Medicine) providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2021: $13.20 · 2022: $53.36 · 2023: $76.45 · 2024: $92.50 · 2025: $2,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,130 · Food and Beverage: $196 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,130.00 |
| Food and Beverage | $196.14 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,434.22 | 2019-2025 | Wegovy |
| Covidien Lp | $37.51 | 2019 | |
| Lilly USA, LLC | $30.51 | 2023-2025 | Zepbound, Jardiance |
| Abbott Laboratories | $17.73 | 2024 | Cardiomems |
| Bayer Healthcare Pharmaceuticals INC. | $16.00 | 2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $13.20 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.38 | 2022 | |
| Amgen INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahtab Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.